Oncotelic Therapeutics, Inc. (OTLC) — S-1/A Filings
All S-1/A filings from Oncotelic Therapeutics, Inc.. Browse 1 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (1)
-
Oncotelic Files S-1/A for Mast Hill's 20.1% Share Resale Amid Going Concern Doubts
— Dec 22, 2025 Risk: high
Oncotelic Therapeutics, Inc. (OTLC) filed an S-1/A on December 22, 2025, for the resale of 115,600,000 shares of common stock by Mast Hill Fund, LP, representin
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX